Interferon Alpha/Beta Receptor 1 (IFNa/bR1) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Interferon Alpha/Beta Receptor 1 (IFNa/bR1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityInterferon Alpha/Beta Receptor 1 (IFNa/bR1)
Clonemonoclonal
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgG
Formataffinity purified
Size0.01 mg, 0.02 mg, 0.05 mg
Concentration500ug/ml
ApplicationsImmunocytochemistry (ICC), Immunohistochemistry (IHC) - Formalin/Paraffin, ELISA (EIA), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody is a mouse monoclonal antibody raised against IFNa/bR1. It has been selected for its ability to recognize IFNa/bR1 in immunohistochemical staining andwestern blotting.
ImmunogenImmunogen: Recombinant IFNa/bR1 (Lys28~Asn227) expressed in E.coli.
Other Names[interferon alpha/beta receptor 1; Interferon alpha/beta receptor 1; interferon alpha/beta receptor 1; CRF2-1; IFN-R-1; IFN-alpha/beta receptor 1; interferon-beta receptor 1; beta-type antiviral protein; alpha-type antiviral protein; type I interferon receptor 1; cytokine receptor class-II member 1; cytokine receptor family 2 member 1; interferon-alpha/beta receptor alpha chain; interferon (alpha, beta and omega) receptor 1; Cytokine receptor class-II member 1; Cytokine receptor family 2 member 1; CRF2-1; Type I interferon receptor 1]
Gene, Accession #[IFNa/bR1], Gene ID: 3454, NCBI: NP_000620.2, UniProt: P17181
Catalog #MBS2012849
Price$105, $110, $145
Order / More InfoInterferon Alpha/Beta Receptor 1 (IFNa/bR1) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.